The global magnetic beads market size reached USD 2.6 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 6.5 Billion by 2033, exhibiting a growth rate (CAGR) of 10.29% during 2025-2033.
Report Attribute
|
Key Statistics
|
---|---|
Base Year
|
2024
|
Forecast Years
|
2025-2033
|
Historical Years
|
2019-2024
|
Market Size in 2024
|
USD 2.6 Billion |
Market Forecast in 2033
|
USD 6.5 Billion |
Market Growth Rate 2025-2033 | 10.29% |
Magnetic beads are tiny particles of iron oxides used in molecular biology for easy and effective isolation of biomolecules. They provide a simple and reliable method of purifying plasmids, genomic and mitochondrial deoxyribonucleic acid (DNA), ribonucleic acid (RNA), and proteins. They are widely utilized in next-generation sequencing (NGS), polymerase chain reaction (PCR), quantitative PCR (qPCR), droplet digital PCR (ddPCR) and other amplification and genotyping applications. They can also find applications as carriers of antigens, antibodies, and catalyzers for tissue-specific targeting and in magnetic resonance imaging (MRI, magnetic particle imaging, and nanomaterial-based catalysis worldwide.
Molecular biology and nanotechnology-based analytical methods are nowadays employed as diagnostic tools for the rapid screening of coronavirus disease (COVID-19) with high accuracy and precision. This represents one of the major factors driving the need for magnetic beads across the globe. Apart from this, the rising preference for in-vitro diagnostic testing on account of their versatility and ability to provide quick results is impelling the market growth. Moreover, a significant increase in the human lifespan and aging of the baby boomer generation is catalyzing the demand for medicines and other studies targeting chronic diseases. This, in turn, is positively influencing the demand for magnetic beads to facilitate disease prevention and treatment methods and the generation of new protein products. Besides this, researchers are studying the efficacy of magnetic beads containing graphite carbon on removing color and organic substances in livestock wastewater. Such innovations are creating a positive influence on the usage of magnetic beads in the agriculture sector. Furthermore, rising investments in genetic and microbiology research activities are projected to provide a thrust to the market.
IMARC Group provides an analysis of the key trends in each sub-segment of the global magnetic beads market report, along with forecasts at the global, regional and country level from 2025-2033. Our report has categorized the market based on type, magnetic core, size and application.
Breakup by Type:
Breakup by Magnetic Core:
Breakup by Size:
Breakup by Application:
Breakup by Region:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Advanced BioChemicals LLC, Bio-Rad Laboratories Inc., Calbiotech Inc, MagBio Genomics Inc., Merck KGaA, New England Biolabs, Promega Corporation, Qiagen N.V., Thermo Fisher Scientific Inc., Vazyme Biotech Co. Ltd., and Xiamen Zeesan Biotech Co. Ltd.
Report Features | Details |
---|---|
Base Year of the Analysis | 2024 |
Historical Period | 2019-2024 |
Forecast Period | 2025-2033 |
Units | Billion USD |
Segment Coverage | Type, Magnetic Core, Size, Application, Region |
Region Covered | Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
Countries Covered | United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
Companies Covered | Advanced BioChemicals LLC, Bio-Rad Laboratories Inc., Calbiotech Inc, MagBio Genomics Inc., Merck KGaA, New England Biolabs, Promega Corporation, Qiagen N.V., Thermo Fisher Scientific Inc., Vazyme Biotech Co. Ltd., and Xiamen Zeesan Biotech Co. Ltd. |
Customization Scope | 10% Free Customization |
Post-Sale Analyst Support | 10-12 Weeks |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
The global magnetic beads market was valued at USD 2.6 Billion in 2024.
We expect the global magnetic beads market to exhibit a CAGR of 10.29% during 2025-2033.
The growing demand for in-vitro diagnostics to conduct clinical tests, along with the increasing requirement for magnetic beads to determine the infection of acute respiratory infection (ARI), is primarily driving the global magnetic beads market.
The sudden outbreak of the COVID-19 pandemic has led to the widespread adoption of molecular biology and nanotechnology-based analytical methods, such as magnetic beads, for the screening of chronic diseases with higher accuracy and precision.
Based on the type, the global magnetic beads market has been segmented into cells, pathogenic microorganisms, nucleic acids, peptide, protein, and others. Currently, cells account for the majority of the total market share.
Based on the magnetic core, the global magnetic beads market can be divided into superparamagnetic and ferrimagnetic, where ferrimagnetic currently exhibits a clear dominance in the market.
Based on the size, the global magnetic beads market has been segregated into less than 5 μm, 5-20 μm, 0-40 μm, and 40 μm and above. Currently, less than 5 μm holds the largest market share.
Based on the application, the global magnetic beads market can be bifurcated into next-generation sequencing, biomolecules separation and purification, molecular and immunodiagnostics, and others. Among these, biomolecules separation and purification exhibits a clear dominance in the market.
On a regional level, the market has been classified into North America, Asia-Pacific, Europe, Latin America, and Middle East and Africa, where North America currently dominates the global market.
Some of the major players in the global magnetic beads market include Advanced BioChemicals LLC, Bio-Rad Laboratories Inc., Calbiotech Inc, MagBio Genomics Inc., Merck KGaA, New England Biolabs, Promega Corporation, Qiagen N.V., Thermo Fisher Scientific Inc., Vazyme Biotech Co. Ltd., and Xiamen Zeesan Biotech Co. Ltd.